Key Metrics of ADC Therapeutics SA
Revenue$69.6M▼ 66.9% YoYFY 2023
Operating income−$166M▼ 34.6% YoY
Net profit−$240M▼ 52.8% YoY
Shareholders' equity−$148M
Market cap$190MADCT · $1.49
Competitors10identified
About ADC Therapeutics SA
Sectors
Company details
- Website
- adctherapeutics.com
- Founded
- 2020
- Listed
- NYSE: ADCT (since 2020)
Operational Areas of ADC Therapeutics SA
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameADC Therapeutics SA
TickerADCT
ExchangeNYSE
CountrySwitzerland
SEC CIK0001771910
Listed since2020
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttps://adctherapeutics.com
US market & SEC filings
ADCT · NYSE · SEC CIK 0001771910
Last price · 31 Oct 2026
$1.49
−8.03%
Market cap$190M
P/E—On FY 2023 diluted EPS
Volume899,762
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOSwitzerlandListed 2020
ADCT share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeLausanne
GSTIN—
Email—
Websitehttps://adctherapeutics.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of ADC Therapeutics SA
Competitors10identified
Countries2most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gsk.com | 2022 | United Kingdom | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | twistbioscience.com | 2018 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.